Submitted by Anonymous (not verified) on 9 October 2023 - 12:58
Human medicines European public assessment report (EPAR): Rybelsus, semaglutide, Diabetes Mellitus, Type 2, Date of authorisation: 03/04/2020, Revision: 6, Status: Authorised
Source: